Parliament Vote On Patient Ombudsman: A Step Forward for Cyprus Healthcare

by News Editor

April 12, 2025

In a noteworthy move, Cyprus’ House of Representatives has endorsed a significant bill introducing a Patient Ombudsman and boosting oversight of the General Healthcare System (GeSY). This marks an essential step in elevating healthcare standards across the nation.

President Nikos Christodoulides has welcomed this development, emphasizing its alignment with his administration’s commitments to prioritize the healthcare system alongside education. In his statement on April 10, he expressed that this enactment is not just a promise fulfilled but a stride in fortifying healthcare services across Cyprus.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Strengthening Patient Rights And Ensuring Effective Management

Establishing the Patient Ombudsman aims to fill an existing gap, providing an independent channel to defend and support patients’ rights. This initiative reflects a longstanding societal demand for a robust mechanism to safeguard healthcare consumer interests.

Meanwhile, the bill fortifying GeSY supervision is a cornerstone for transparency and accountability. It pledges a well-managed, sustainable healthcare system, ensuring Cyprus’s health services remain robust for future generations.

The Future Forbes Realty Global Properties

Reid Hoffman Leaves Microsoft Board To Focus On Manus AI

by THEFUTURE.TEAM

June 8, 2026

Former Microsoft board member Reid Hoffman has stepped down from the company’s board, marking a return to startup building and investment activities. Hoffman joined Microsoft’s board following the company’s $26.2 billion acquisition of LinkedIn in 2016.

Strategic Investment And Board Leadership

During his time on the board, Hoffman was involved in a period of significant investment in artificial intelligence, including Microsoft’s first $1 billion investment in OpenAI in 2019. As an early investor in OpenAI, Hoffman also served on the organisation’s board before stepping down in 2023 to avoid potential conflicts of interest.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Acqui-Hire Deals And AI Synergies

Hoffman’s board tenure coincided with significant strategic moves, including Microsoft’s $650 million acqui-hire deal involving his AI startup, Inflection AI. This arrangement, which saw Microsoft adding Inflection co-founder Mustafa Suleyman to its ranks, highlights the increasingly blurred lines between corporate reinvention and startup innovation in the tech landscape.

Return to Founder Mode With Manus AI

In a recent conversation on his “Possible” podcast with Microsoft CEO Satya Nadella, Hoffman revealed his excitement to return to “founder mode” with his latest venture, Manus. This AI-driven drug discovery startup has already raised over $50 million through early seed rounds, marking it as a promising player in the competitive field of AI in healthcare.

Leadership Under Visionary Guidance

Hoffman serves as co-founder and chair of Manus AI. Day-to-day leadership is led by Dr. Siddhartha Mukherjee, a physician, biologist and Pulitzer Prize-winning author of The Emperor of All Maladies: A Biography of Cancer. The company is focused on applying artificial intelligence to chemistry and drug discovery, including research related to cancer treatment. Hoffman’s departure from Microsoft’s board comes as he increases his focus on new ventures in artificial intelligence and healthcare.

Breaking news